InvestorsHub Logo
Followers 134
Posts 3746
Boards Moderated 0
Alias Born 01/28/2006

Re: BooDog post# 221789

Wednesday, 03/21/2018 1:04:44 PM

Wednesday, March 21, 2018 1:04:44 PM

Post# of 403039
IPIX announced in 12/2016 it had engaged a CRO to begin preliminary lab testing for oral Kevetrin.

"On the basis of these results, Cellceutix has now selected CROs to perform the additional nonclinical studies, including necessary bridging toxicology, required to support clinical dosing of Kevetrin via the oral route. Additional laboratory research is underway to further expand these findings."

It is possible they are further along with these necessary studies than most believe.

Farrell

http://www.ipharminc.com/press-release/2016/12/14/p87o1t8af2wn9fxtnapze33i3z6z29
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News